Articles: Central Nervous System/Neurological

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles
Browse

Articles

Displaying 1..8 of 8 - per page
Order by

Essentially, migraine is a severe pain in the head, usually one-sided, that is frequently associated with nausea and vomiting. More

A Tour around Stroke

A 'stroke' is a fairly innocuous term for what can be a terrifying medical emergency - perhaps the American use of 'brain attack' is more appropriate. More

Epilepsy

With many treatments available, the pipeline for new drugs to treat this enigmatic disease is thin. More

Endo Pharmaceuticals/Vernalis' frovatriptan: The partnership of 2004

In 2004, Worldwide Business Research and Pharmalicensing jointly awarded Endo Pharmaceuticals and Vernalis the BioBusiness Network Innovative Partnership 2004 award More

An Interview with Neurotech Executive Vice President and Chief Financial Officer Bernard Davitian (with additional comments from Mark Clement of Merlin Biosciences)

This interview with Neurotech's Executive Vice President and Chief Financial Officer looks at the company's funding and development. More

BioIsrael Insight: Ester Neurosciences Challenges Conventional Wisdom

Ester Neurosciences is developing a unique, disease-modifying approach to combat neurological disorders that result from disrupted acetlycholinesterase (AChE) neuromodulation More

A Tour around new pharmacological treatments for ADHD

This article looks at new developments in an area largely bereft of pharmacological advances for several years. More

A Tour around new drugs for stroke

For years the pharmacological management of stroke languished in the shadows cast by heart dent developments this could soon change. More

Displaying 1..8 of 8 - per page
Order by

Your selection

Therapeutic target: Central Nervous System del; Neurological del

Browse By

Industry sector: Academic/Research; Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Non-profit org./Government; Pharmaceutical; Research tools; Service
Therapeutic target: Attention-deficit/hyperactivity disorder; Autism; Brain injury; Cerebral palsy; Cerebrovascular disorders; Dyslexia; Emesis; Encephalitis; Epilepsy; Huntington's disease; Hypersomnia; Insomnia; Meningitis, aseptic; Meningitis, bacterial; Meningitis, viral; Migraine; Myalgic encephalomyelitis; Narcolepsy; Neoplastic meningitis; Nerve regeneration; Neuropathy, AIDS-related; Neuropathy, diabetic; Neuropathy, peripheral; Neuroprotection; Premenstrual dysphoric disorder; Sleep apnea; Sleep disorders; Spasticity; Spinal cord injury; Stroke; Tourette's syndrome; Vertigo
Year: 2009; 2008; 2007; 2006; 2005; 2004; 2003; 2002; 2001; 2000; 1999

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us